Loading provider…
Loading provider…
Nephrology Physician in Port Charlotte, FL
NPI: 1174524219Primary Practice Location
Arcadia Dialysis Center
3300 Tamiami Trl, Port Charlotte, FL
Primary Employer
Florida Kidney Physicians, LLC
flkidney.com
HQ Phone
Get DO Kianoosh's Phone Numberphone_androidMobile
Get DO Kianoosh's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardFL State Medical License

FL State License
2000 - 2026

DC State License
1999 - 2000

AZ State License
1996 - 1999

AOA Board of Internal Medicine
Nephrology
WesternU College of Osteopathic Medicine of the Pacific
westernu.edu
Medical School
Until 1995
George Washington University
Fellowship • Nephrology
1998 - 2000
Creighton University School of Medicine/Maricopa Medical Center (Phoenix)
Residency • Internal Medicine
1995 - 1998
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 408 | 965 |
| 2 | 99232Subsequent hospital inpatient care, typically 25 minutes per day | 279 | 740 |
| 3 | 99233Subsequent hospital inpatient care, typically 35 minutes per day | 151 | 287 |
| 4 | 99223Initial hospital inpatient care, typically 70 minutes per day | 128 | 138 |
| 5 | 99213Established patient office or other outpatient visit, typically 15 minutes | 94 | 110 |
Compliance in Hemodialysis Patients: Multidimensional Measures in Search of a Gold Standard
Authors: Kaveh, K, Kimmel, P L
Journal: Am J Kidney Dis
Dialysis access related infections.
Authors: Kian Kaveh
Journal: ASAIO J
Lead Sponsor: Biogen
Intervention / Treatment: DRUG: Placebo oral capsule, DRUG: Bardoxolone methyl oral capsule
Lead Sponsor: Kadmon, a Sanofi Company
Intervention / Treatment: DRUG: Placebo, DRUG: Tesevatinib
Lead Sponsor: GlaxoSmithKline
Intervention / Treatment: DRUG: Placebo, DRUG: Darbepoetin alfa, DRUG: Iron Therapy, DRUG: Daprodustat